Vir Biotechnology, Inc.
NASDAQVir Biotechnology heads into the first week of June with a deteriorating price chart, rising short interest, and one bullish analyst move that hasn't stopped the stock from falling — a gap worth examining closely. The price tells a bleak short-term story. VIR closed at $8.74 on June 2, down 3.2% on the day, 6.8% on the week, and 12.6% over the past month. The stock is now trading at…
Snapshot as of 22 Jun 2026
Vir Biotechnology heads into the first week of June with a deteriorating price chart, rising short interest, and one bullish analyst move that hasn't stopped the stock from falling — a gap worth examining closely. The…
Vir Biotechnology heads into its May 26 earnings date with options traders the most defensively positioned they have been all year — even as short sellers quietly trim their exposure. The options signal is the sharpest…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for VIR — free to start on ORTEX.
Sign up for free →Open VIR on ORTEX